Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron Augmentation in Treatment-resistant OCD
NCT01303536Phase 4Completed
- Sponsor
- Institute of Neuroscience, Florence
- Start
- Dec 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ondansetron in obsessive compulsive disorder (OCD), sponsored by Institute of Neuroscience, Florence. Started Dec 2009; status: completed.
02
Drugs
ondansetron
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT01303536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01303536.